Page 3 - Stocks To Buy

Vinay Rajani of HDFC Securities recommends Buy on KIMS, United Spirits

On the broader market outlook, the technical analyst sees 18,350 as the next resistance for the Nifty 50, and support at 17,800-level.

Pharma shares may turnaound soon; Cipla, Sun Pharma, Granules can gain 20%

What do expect from pharma stocks over the next few weeks? Here's what technical charts suggest.

Mehul Kothari recommends to buy Astral, Just Dial on dips; Check Why

According to the technical analyst from Anand Rathi, Astral can be bought with a stop at Rs 1,940, and Just Dial can be purchaced closer to Rs 620.

Flying high! SBI, BoB, Canara Bank poised for up to 18% rally, charts show

The Nifty PSU Bank index hit a fresh 52-week high on Friday and has gained 15 per cent so far this month. The index can rally another 4 per cent.

PNB, BHEL, IDFC among top mid-, smallcap stocks that can rally up to 25%

Technically, whenever any stock remains unaffected during times of volatility, the trend indicates something positive underneath. Such stocks are preferred by market participants for trading gains.

Q2 impact: Upside of up to 14% on cards for ITC, Axis Bank, Dixon Tech

Among prominent stocks, ITC, Dixon Technologies, Axis Bank and Bajaj Finance seem poised to rally up to 14 per cent; whereas Asian Paints is seen testing the crucial 200-DMA level at Rs 3,131.

Here's why Mehul Kothari expects Axis Bank to hit Rs 1,000-mark

According to the technical analyst from Anand Rathi, a weekly close above Rs 825, can potentially trigger a massive rally in Axis Bank up to Rs 1,000-mark.

TVS, Eicher Motors may be the best bets among two-wheeler stocks; check why

On the other hand, Bajaj-Auto and Hero Moto Corp need to adhere their key supports levels to keep the positive bias intact.

Diwali cheer: PC Jeweller, Kalyan Jewellers may gain up to 40%, hint charts

So far this month, PC Jeweller, Rajesh Exports and Kalyan Jewellers have rallied up to 21 per cent on hopes of a bumper sales this Diwali season.

Support zone for Nifty shifted higher to 17,200-17,300, says Vinay Rajani

Among individual stocks, the technical analyst from HDFC Securities recommends buying IndusInd Bank and Mahindra CIE.

Mehul Kothari recommends Arvind Fashions, CAMS as top 'Diwali' picks

According to the technical analyst from Anand Rathi, Arvind Fashions can rally to Rs 440, while CAMS can surge to Rs 3,650 within a year's time.

HDFC Bank can rally 10% if it conquers Rs 1,550-hurdle, chart indicates

The trend seems buoyant on the weekly chart with the 200-WMA, placed at Rs 1,285-level, acting as a major support for the stock.

Here's why Mehul Kothari recommends buying Gland Pharma, Indian Oil

According to the technical analyst from Anand Rathi, Gland Pharma can rally to Rs 2,350, while IOC can spurt to Rs 83.

Here's why Vinay Rajani is bullish on KIMS, Pfizer; bearish on Nifty

On the broader market outlook, the technical analyst from HDFC Securities says that the indicators and oscillators have turned bearish on the short term charts for the Nifty 50.

Mehul Kothari recommends Buy on CAMS, Pfizer; Check Why

According to the technical analyst from Anand Rathi, CAMS can rally to Rs 2,700, while Pfizer can be bought for a target of Rs 4,700.

Vedanta, JSW can soar up to 18% as Nifty Metal eyes 'Golden Cross' breakout

The Nifty Metal index can rally up to 11 per cent following the breakout. Among individual stocks, Tata Steel needs to conquer its 200-DMA to gain strength.

Brickwork impact: Charts favour Icra; CRISIL, CARE Ratings test key levels

ICRA and CRISIL have gained up to 22 per cent so far this year, while Care Ratings has been a underperformer, down 14 per cent.

Mehul Kothari recommends these 2 stocks on 'Symmetrical Triangle' breakout

According to the technical analyst from Anand Rathi, Godfreh Phillips can jump to Rs 1,320, while Zydus Wellness can be bought for a target of Rs 1,860.

Vinay Rajani of HDFC Securities expects markets to remain bullish for now

Among individual stocks, the technical analyst recommends buying JK Tyre and J.B.Chemicals & Pharma.

Nifty Pharma index surpasses 200-DMA; Cipla, Granules can soar up to 15%

The Pharma benchmark has outperformed the overall market in recent trading sessions; sustenance above 200-DMA is likely to trigger further gains for it